PMCPA Case Library

1,752 PMCPA Rulings.
Every One Analysed.

The only structured, searchable PMCPA case library in the UK. Expert video walkthroughs, podcast episodes, and MCQ assessments on every ruling — so you understand why companies breach the Code, not just that they did.

▶ Video analysis per case
🎧 Podcast per case
✍ MCQ + CPD certificate
🔒 From £299/year
1752+
Case Studies
5 min
Per Video
5 pts
Per Case Passed
8
Themes
📚
Subscribe for full case library access
Read free summaries below, or subscribe to unlock expert video walkthroughs, podcast audio and CPD certificates.
Sign in See plans ↓
Free — Browsing
✓ Browse all 1752+ case titles
✓ Filter by theme & therapy area
✓ See case reference, company & outcome
✗ Search by company or clause
✗ Video walkthroughs
✗ Podcast episodes
✗ MCQ assessments & CPD certificates
Subscribed — Full Access
✓ Search by company, clause & case ref
✓ Expert video walkthrough per case
✓ Podcast episode per case
✓ MCQ quiz — 5 CPD points per pass
✓ Personalised CPD completion certificate
✓ New cases added monthly
Subscribe from £299/year →
Search by company, clause, case reference... 🔒
All (1752) Social Media & Digital (720) HCP Hospitality & Meetings (431) Data & Publications (321) Off-label Promotion (219) Patient Organisations (44) Transfers of Value (9) Promotional Material (4) Samples & Gifts (2)
Therapy Area: All areas Other (360) Oncology (218) Cardiovascular (189) Respiratory (178) CNS & Neurology (169) Infectious Diseases (115) Diabetes (114) Rare Diseases (104) Immunology & Rheumatology (84) Dermatology (67) Obesity & Weight Management (63) Musculoskeletal & Bone (60) Ophthalmology (31)
Showing 321 results · Data & Publications  · Clear
🔒 Subscribers only
AUTH/3870/1/24
Data & Publications Upheld 🏥 Other ▶ Video 🎙 Podcast
AstraZeneca
A complaint was made against AstraZeneca concerning allegations about clinical trial material.The PMCPA determined the matter was outwith the scope of the ABPI Code of Practice.
Clauses: NONE
2024 🔒 Subscribe
🔒 Subscribers only
AUTH/3757/3/23
Data & Publications Not Upheld 🏥 Other ▶ Video 🎙 Podcast
Otsuka criticised for lack of transparency in PMCPA submission about
A named ex-employee complained about Otsuka’s submission to the PMCPA in an earlier case completed in 2015 (Case AUTH/2752/3/15).The complainant alleged Otsuka failed to disclose relevant informa…
Clauses: NONE
2023 🔒 Subscribe
🔒 Subscribers only
AUTH/3614/2/22
Data & Publications Not Upheld 🏥 Infectious Diseases ▶ Video 🎙 Podcast
Eli Lilly
An Eli Lilly employee complained about the alleged conduct of another Lilly employee (their manager).The concern: the manager allegedly suggested the complainant should “dress down” (dress more…
Clauses: NONE
2022 🔒 Subscribe
🔒 Subscribers only
AUTH/3454/1/21
Data & Publications Not Upheld 🏥 Diabetes ▶ Video 🎙 Podcast
Sanofi
An anonymous, non-contactable complainant (describing themselves as a Sanofi representative) raised concerns about briefing materials for Toujeo Coach, a patient support programme for adults prescr…
Clauses: NONE
2021 🔒 Subscribe
🔒 Subscribers only
AUTH/3487/3/21
Data & Publications Not Upheld 🏥 Infectious Diseases ▶ Video 🎙 Podcast
Sanofi
An NHS commissioning manager complained that Sanofi staff encouraged ordering quadrivalent influenza vaccine egg-grown (QIVe) contrary to official NHS guidance which positioned QIVe as second-line …
Clauses: NONE
2021 🔒 Subscribe
🔒 Subscribers only
AUTH/3508/5/21
Data & Publications Upheld 🏥 Infectious Diseases ▶ Video 🎙 Podcast
Advanz Pharma
A general practitioner complained (to the MHRA) about an Advanz Pharma Services (UK) Limited promotional email for Macrobid (nitrofurantoin) titled “Minimising antimicrobial resistance in lower u…
Clauses: 9.1,9.2,12.1
2021 🔒 Subscribe
🔒 Subscribers only
AUTH/3544/7/21
Data & Publications Not Upheld 🏥 CNS & Neurology ▶ Video 🎙 Podcast
Lundbeck
An anonymous, contactable complainant alleged that between July 2020 and June 2021 Lundbeck sales representatives were not briefed on how often health professionals could be called upon.The complai…
Clauses: NONE
2021 🔒 Subscribe
🔒 Subscribers only
AUTH/3560/9/21
Data & Publications Not Upheld 🏥 Diabetes ▶ Video 🎙 Podcast
Anonymous health professional complaint about pressure to sign up to diabetes review service (No bre
An anonymous, non-contactable complainant (describing themself as a nurse) alleged a named Sanofi diabetes representative (account executive) repeatedly asked them to sign up to a diabetes review s…
Clauses: NONE
2021 🔒 Subscribe
🔒 Subscribers only
AUTH/3543/7/21
Data & Publications Not Upheld 🏥 Obesity & Weight Management ▶ Video 🎙 Podcast
Eli Lilly
Novo Nordisk complained about Eli Lilly’s promotional presentation, ‘Barber’s Box comparison of GLP‑1 receptor agonists’ (PP-DG-GB-0573, January 2020), used to compare dulaglutide (Trulic…
Clauses: NONE
2021 🔒 Subscribe
🔒 Subscribers only
AUTH/3534/7/21
Data & Publications Not Upheld 🏥 CNS & Neurology ▶ Video 🎙 Podcast
Janssen
Astellas complained about a Janssen Medical Cloud webpage titled “Zytiga Quality of Life” promoting Zytiga (abiraterone acetate) in mCRPC. The page presented multiple QoL/HRQoL claims and chart…
Clauses: NONE
2021 🔒 Subscribe
🔒 Subscribers only
AUTH/3365/7/20
Data & Publications Upheld 🏥 Rare Diseases ▶ Video 🎙 Podcast
Norgine breached ABPI Code over Feraccru email claiming major cost and nursing-time savings vs IV ir
A UK health professional complained about a promotional email for Feraccru (ferric maltol) sent via Guidelines in Practice to prescribers, commissioners and NHS decision makers.The email headline a…
Clauses: 9.1,9.2
2020 🔒 Subscribe
🔒 Subscribers only
AUTH/3366/7/20
Data & Publications Not Upheld 🏥 Ophthalmology ▶ Video 🎙 Podcast
Bayer v Novartis
Bayer complained about a Novartis journal advertisement for Beovu (brolucizumab) in Eye News (April 2020), ref BRO20-CO22 (March 2020). The ad included a prominent headline claim in dark pink: “O…
Clauses: NONE
2020 🔒 Subscribe
🔒 Subscribers only
AUTH/3429/11/20
Data & Publications Not Upheld 🏥 Other ▶ Video 🎙 Podcast
Sanofi
A member of the public raised additional allegations following an earlier case (AUTH/3281/11/19) about interactions with Sanofi.The complainant alleged that during a medical information call-back, …
Clauses: NONE
2020 🔒 Subscribe
🔒 Subscribers only
AUTH/3182/4/19
Data & Publications Not Upheld 🏥 Immunology & Rheumatology ▶ Video 🎙 Podcast
Astellas breached ABPI Code after repeated calls to pharmacist who said they didn’t speak to industr
A pharmacist responsible for introducing new medicines to a state-funded pharmaceutical service complained about the frequency of telephone calls from Astellas representatives.The calls related mai…
Clauses: NONE
2019 🔒 Subscribe
🔒 Subscribers only
AUTH/3285/12/19
Data & Publications Not Upheld 🏥 Other ▶ Video 🎙 Podcast
Daiichi-Sankyo voluntary admission
An ex-employee complained that Daiichi-Sankyo’s 2018 Disclosure UK entries showed healthcare professional registration fees of £7,937.60 for named individuals and zero in aggregate, which the co…
Clauses: NONE
2019 🔒 Subscribe
🔒 Subscribers only
AUTH/3223/7/19
Data & Publications Upheld 🏥 Respiratory ▶ Video 🎙 Podcast
Boehringer Ingelheim
Boehringer Ingelheim Limited voluntarily admitted that the June 2019 issue of MIMS bore advertising for Spiolto Respimat (tiotropium and olodaterol) on more than two pages.The June 2019 MIMS contai…
Clauses: 9.1
2019 🔒 Subscribe
🔒 Subscribers only
AUTH/3159/2/19
Data & Publications Not Upheld 🏥 Rare Diseases ▶ Video 🎙 Podcast
Vifor
Pharmacosmos complained that Vifor medical personnel proactively contacted UK health professionals to discuss safety data from Ehlken et al (2018) about severe hypersensitivity reactions, comparing…
Clauses: NONE
2019 🔒 Subscribe
🔒 Subscribers only
AUTH/3243/9/19
Data & Publications Not Upheld 🏥 Dermatology ▶ Video 🎙 Podcast
Ex-employee complaint about Allergan commercial policy (Botox, Juvederm, CoolSculpting)
An ex-employee complained about Allergan’s commercial policy for aesthetic products: Botox (POM) and the medical devices Juvederm and CoolSculpting.The complainant alleged a “commercial overlay…
Clauses: NONE
2019 🔒 Subscribe
🔒 Subscribers only
AUTH/3199/5/19
Data & Publications Upheld 🏥 Infectious Diseases ▶ Video 🎙 Podcast
Vifor Pharma
Pharmacosmos alleged Vifor breached undertakings given in earlier cases (AUTH/2830/3/16 and AUTH/2828/3/16) while promoting Ferinject (ferric carboxymaltose) against Pharmacosmos’ Monofer (iron i…
2019 🔒 Subscribe
🔒 Subscribers only
AUTH/3218/6/19
Data & Publications Not Upheld 🏥 CNS & Neurology ▶ Video 🎙 Podcast
Otsuka UK breached ABPI Code over Abilify Maintena detail aid
An anonymous, contactable ex-employee complained about an electronic detail aid for Abilify Maintena (aripiprazole) titled “Take the next step in the disease journey with Abilify Maintena” (ref…
Clauses: NONE
2019 🔒 Subscribe
🔒 Subscribers only
AUTH/3259/10/19
Data & Publications Not Upheld 🏥 Rare Diseases ▶ Video 🎙 Podcast
Otsuka Europe
An employee complained about Otsuka Europe regarding EU risk minimisation plan (RMP) / additional risk minimisation measures (aRMM) materials for Jinarc (tolvaptan), alleging patient safety risk an…
Clauses: NONE
2019 🔒 Subscribe
🔒 Subscribers only
AUTH/3137/12/18
Data & Publications Upheld 🏥 Infectious Diseases ▶ Video 🎙 Podcast
Gilead
ViiV Healthcare UK Ltd alleged Gilead Sciences Europe Ltd breached an undertaking given in Case AUTH/3137/12/18 by continuing to use the claim that Biktarvy (bictegravir/emtrictabine/tenofovir) was…
Clauses: 9.1
2018 🔒 Subscribe
🔒 Subscribers only
AUTH/3096/9/18
Data & Publications Not Upheld 🏥 Rare Diseases ▶ Video 🎙 Podcast
AUTH/3096/9/18 Director v Shire
Clauses: NONE
2018 🔒 Subscribe
🔒 Subscribers only
AUTH/3135/12/18
Data & Publications Upheld 🏥 Musculoskeletal & Bone ▶ Video 🎙 Podcast
Astellas breached ABPI Code over unqualified ‘more patients stay on Betmiga’ persistence claim in Pu
A concerned health professional complained about a Betmiga (mirabegron) advertisement (ref BET18035UKa) published in the December 2018 edition of Pulse.The ad’s headline claim stated: “More OAB…
Clauses: 3.2,4.1
2018 🔒 Subscribe
1 2 3 4 Next → Page 1 of 14 — 321 cases
Unlock the Full Case Library
Annual subscription — instant access, cancel anytime.
🏆
The only PMCPA case library of its kind
No other provider publishes a structured, searchable library of PMCPA rulings with video and podcast. A single half-day compliance workshop from a specialist provider typically costs £499+ — for one session. Individual access here is £299 for a full year of 2,000+ cases.
PMCPA Case Library — Team (100 seats)
Custom pricing
tailored to your team size
Bulk pricing available — contact us for a quote
Enquire for bulk pricing →
Individual
For a single learner
£299
per year
Less than a single half-day workshop
  • 1 user seat
  • All 1752+ case studies
  • Video + podcast per case
  • MCQ quiz per case
  • 5 points per case passed
  • New cases added monthly
Create account or sign in to buy
Most Popular
Team 5
Up to 5 team members
£999
per year (£200/seat)
£200/person — the most cost-effective team option
  • 5 user seats
  • All case studies included
  • Video, podcast & MCQ per case
  • Team progress dashboard
  • New cases added monthly
  • Admin management portal
Create account or sign in to buy
Team 25+
25+ team members
Custom pricing
tailored to your team size
Bulk pricing available — contact us for a quote
  • 25 user seats
  • All case studies included
  • Video, podcast & MCQ per case
  • Team progress dashboard
  • Bulk seat management
  • Priority support
Enquire for bulk pricing →

Questions? Email [email protected]  ·  14-day money-back guarantee  ·  Annual subscription, auto-renews